1. Home
  2. UA vs AMRX Comparison

UA vs AMRX Comparison

Compare UA & AMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Under Armour Inc. Class C

UA

Under Armour Inc. Class C

HOLD

Current Price

$5.73

Market Cap

3.4B

ML Signal

HOLD

Logo Amneal Pharmaceuticals Inc.

AMRX

Amneal Pharmaceuticals Inc.

HOLD

Current Price

$16.11

Market Cap

4.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UA
AMRX
Founded
1996
2002
Country
United States
United States
Employees
14400
N/A
Industry
Apparel
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.4B
4.0B
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
UA
AMRX
Price
$5.73
$16.11
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$15.60
AVG Volume (30 Days)
2.8M
1.9M
Earning Date
05-12-2026
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
157.89
EPS
N/A
0.19
Revenue
N/A
N/A
Revenue This Year
N/A
$4.48
Revenue Next Year
$1.57
$7.13
P/E Ratio
N/A
$85.32
Revenue Growth
N/A
N/A
52 Week Low
$3.95
$7.67
52 Week High
$7.91
$16.61

Technical Indicators

Market Signals
Indicator
UA
AMRX
Relative Strength Index (RSI) 51.97 75.53
Support Level $5.24 $12.46
Resistance Level $5.95 N/A
Average True Range (ATR) 0.23 0.57
MACD 0.04 0.21
Stochastic Oscillator 62.13 87.01

Price Performance

Historical Comparison
UA
AMRX

About UA Under Armour Inc. Class C

Under Armour develops, markets, and distributes athletic apparel, footwear, and accessories in North America, Asia-Pacific, Europe, and Latin America. Consumers of its performance-based clothing and shoes include professional and amateur athletes, sponsored college and professional teams, and people with active lifestyles. The company sells merchandise through wholesale partners, company-owned digital channels, and approximately 450 company-owned outlet and full-price stores. The Baltimore-based firm was founded in 1996 and is led by controlling shareholder Kevin Plank.

About AMRX Amneal Pharmaceuticals Inc.

Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE. It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment, which derives maximum revenue, focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

Share on Social Networks: